期刊的影响因子--文章列表

期刊文章列表
Hao Cai¹，Yufan Xiang¹，Yujun Zeng¹，Zhiqian Li¹，Xiuli Zheng¹，Qiang Luo¹，Hongyan Zhu²，Qiyong Gong¹，Zhongwei Gu¹，Yanhui Liu¹，Hu Zhang³，Kui Luo¹（Huaxi MR Research Center(HMRRC)，Department of Neurosurgery，and Department of Radiology，Functional and Molecular Imaging Key Laboratory of Sichuan Province，West China Hospital，Sichuan University；Laboratory of Stem Cell Biology，West China Hospital，Sichuan University；Amgen Bioprocessing Centre，Keck Graduate Institute）.Cathepsin B-responsive and gadolinium-labeled branched glycopolymer-PTX conjugate-derived nanotheranostics for cancer treatment[J].Acta Pharmaceutica Sinica B,2021,第2期 Shaojun Peng^1,2，Boshu Ouyang³，Yongjie Xin¹，Wei Zhao¹，Shun Shen⁴，Meixiao Zhan¹，Ligong Lu¹（Zhuhai Precision Medical Center，Zhuhai Interventional Medical Center，Zhuhai People’s Hospital(Zhuhai Hospital Affiliated with Jinan University)；The Institute for Translational Nanomedicine，Shanghai East Hospital，Tongji University School of Medicine；Central Laboratory，First Affiliated Hospital，Institute of Integrative Medicine，Dalian Medical University；Zhejiang Cancer Hospital，Institute (College) of Cancer Research）.Hypoxia-degradable and long-circulating zwitterionic phosphorylcholine-based nanogel for enhanced tumor drug delivery[J].Acta Pharmaceutica Sinica B,2021,第2期 Qian Wei¹，Jian Bai¹，Daojiang Yan¹，Xiuqi Bao¹，Wenting Li²，Bingyu Liu¹，Dan Zhang¹，Xiangbing Qi²，Dequan Yu¹，Youcai Hu¹（State Key Laboratory of Bioactive Substance and Function of Natural Medicines，Institute of Materia Medica，Chinese Academy of Medical Sciences & Peking Union Medical College；National Institute of Biological Sciences）.Genome mining combined metabolic shunting and OSMAC strategy of an endophytic fungus leads to the production of diverse natural products[J].Acta Pharmaceutica Sinica B,2021,第2期 Zhiming Zhangy，Chenlu Huangy，Li Zhang，Qing Guo，Yu Qin，Fan Fan，Boxuan Li，Bao Xiao，Dunwan Zhu，Linhua Zhang（Tianjin Key Laboratory of Biomedical Materials，Key Laboratory of Biomaterials and Nanotechnology for Cancer Immunotherapy，Institute of Biomedical Engineering，Chinese Academy of Medical Sciences & Peking Union Medical College）.pH-sensitive and bubble-generating mesoporous silica-based nanoparticles for enhanced tumor combination therapy[J].Acta Pharmaceutica Sinica B,2021,第2期 Pengzhao Shang¹，Rui Gao¹，Yijia Zhu¹，Xiaorui Zhang¹，Yang Wang¹，Minji Guo¹，Hui Peng²，Min Wang¹，Juan Zhang¹（Antibody Engineering Laboratory，School of Life Science & Technology，China Pharmaceutical University；Department of Operational Medicine，Tianjin Institute of Environmental & Operational Medicine）.VEGFR2-targeted antibody fused with IFNamut regulates the tumor microenvironment of colorectal cancer and exhibits potent anti-tumor and anti-metastasis activity[J].Acta Pharmaceutica Sinica B,2021,第2期 Xinran Cai¹，Ye Feng^1,2，Meishu Xu¹，Chaohui Yu³，Wen Xie^1,4（Center for Pharmacogenetics and Department of Pharmaceutical Sciences，University of Pittsburgh；Department of Endocrinology and Metabolic Disease，the First Affiliated Hospital，Zhejiang University School of Medicine；Department of Gastroenterology，the First Affiliated Hospital，Zhejiang University School of Medicine；Department of Pharmacology and Chemical Biology，University of Pittsburgh）.Gadd45b is required in part for the anti-obesity effect of constitutive androstane receptor(CAR)[J].Acta Pharmaceutica Sinica B,2021,第2期 Keqi Wang¹，Yongyan Chen¹，Shuo Gao¹，Maosi Wang¹，Mengmeng Ge¹，Qian Yang¹，Mingkai Liao¹，Lin Xu¹，Junjie Chen^1,2，Zhiping Zeng^1,2，Haifeng Chen¹，Xiao-kun Zhang^1,2，Ting Lin¹，Hu Zhou^1,2（School of Pharmaceutical Sciences，Fujian Provincial Key Laboratory of Innovative Drug Target Research，Xiamen University；High Throughput Drug Screening Platform，Xiamen University）.Norlichexanthone purified from plant endophyte prevents postmenopausal osteoporosis by targeting ERa to inhibit RANKL signaling[J].Acta Pharmaceutica Sinica B,2021,第2期 Dominik Bakalarz^1,2，Marcin Surmiak^1,3，Xiaoxiao Yang⁴，Dagmara Wójcik¹，Edyta Korbut¹，Zbigniew ?liwowski¹，Grzegorz Ginter¹，Grzegorz Buszewicz⁵，Tomasz Brzozowski¹，Jakub Cieszkowskia¹，Urszula G?owacka¹，Katarzyna Magierowska¹，Zhixiang Pan⁴，Binghe Wang⁴，Marcin Magierowski¹（Department of Physiology，Jagiellonian University Medical College；Department of Forensic Toxicology，Institute of Forensic Research；Department of Internal Medicine，Jagiellonian University Medical College；Department of Chemistry and Center for Diagnostics and Therapeutics，Georgia State University；Department of Forensic Medicine，Medical University of Lublin）.Organic carbon monoxide prodrug, BW-CO-111, in protection against chemically-induced gastric mucosal damage[J].Acta Pharmaceutica Sinica B,2021,第2期 Yunkai Yang¹，Xiaohan Guo¹，Bo Hu²，Peng He¹，Xiaowu Jiang³，Zuohuan Wang⁴，Huaxing Zhu²，Lina Hu⁵，Minghua Yu⁵，Meiqing Feng¹（Shanghai Engineering Research Center of Immuno Therapeutics，School of Pharmacy，Fudan University；Shanghai Novoprotein Biotechnology Co.，Ltd.；Medical School of Yichun University；Clinical Research Center，2nd Affiliated Hospital，Medical College of Zhejiang University；Department of Oncology，Shanghai Pudong Hospital，Fudan University Pudong Medicine Center）.Generated SecPen＿NY-ESO-1＿ubiquitin-pulsed dendritic cell cancer vaccine elicits stronger and specific T cell immune responses[J].Acta Pharmaceutica Sinica B,2021,第2期 Xiaohua Liu^1,2,3，Yu Zhang⁴，Yalei Li⁵，Juan Wang⁴，Huaqian Ding^1,3，Wenjing Huang⁴，Chunyong Ding^1,2，Hongchun Liu⁵，Wenfu Tan⁴，Ao Zhang^1,2,6,3,7（CAS Key Laboratory of Receptor Research，Shanghai Institute of Materia Medica (SIMM)，Chinese Academy of Sciences；School of Pharmacy，Shanghai Jiao Tong University；University of Chinese Academy of Sciences；Department of Pharmacology，School of Pharmacy，Fudan University；State Key Laboratory of Drug Research，Shanghai Institute of Materia Medica (SIMM)，Chinese Academy of Sciences；School of Life Science and Technology，Shanghai Tech University；State Key Laboratory of Esophageal Cancer Prevention and Treatment，Ministry of Education of China，Zhengzhou University）.Development of hedgehog pathway inhibitors by epigenetically targeting GLI through BET bromodomain for the treatment of medulloblastoma[J].Acta Pharmaceutica Sinica B,2021,第2期 Hu Zhou¹，Gang He²，Yanbin Sun²，Jingguo Wang²，Haitao Wu²，Ping Jin¹，Zhengbao Zha²（Shenzhen Maternity and Child Healthcare Hospital，Shandong University；School of Food and Biological Engineering，School of Instrument Science and Opto-Electronics Engineering，Hefei University of Technology）.Cryptobiosis-inspired assembly of “AND” logic gate platform for potential tumor-specific drug delivery[J].Acta Pharmaceutica Sinica B,2021,第2期 Qiaozhen Wang¹，Xiaolong Tang²，Ping Dai¹，Chuanxi Wang¹，Weiyang Zhang²，Guodong Chen¹，Kui Hong³，Dan Hu¹，Hao Gao¹，Xinsheng Yao¹（Institute of Traditional Chinese Medicine and Natural Product/Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research，College of Pharmacy，Jinan University；Institute of Synthetic Biology，Shenzhen Institutes of Advanced Technology，Chinese Academy of Sciences；Key Laboratory of Combinatorial Biosynthesis and Drug Discovery，Ministry of Education，School of Pharmaceutical Sciences，Wuhan University）.A four-protein metabolon assembled by a small peptide protein creates the pentacyclic carbonate ring of aldgamycins[J].Acta Pharmaceutica Sinica B,2021,第2期 Editoral Office of Acta Pharmaceutica Sinica（Editoral Office of Acta Pharmaceutica Sinica）.Information for Authors[J].Acta Pharmaceutica Sinica B,2021,第2期 Hongxia Duan^1,2，Yanhong Liu^1,2，Zhonggao Gao^1,2，Wei Huang^1,2（State Key Laboratory of Bioactive Substance and Function of Natural Medicines，Department of Pharmaceutics，Institute of Materia Medica，Chinese Academy of Medical Sciences and Peking Union Medical College；Beijing Key Laboratory of Drug Delivery Technology and Novel Formulations，Institute of Materia Medica，Chinese Academy of Medical Sciences and Peking Union Medical College）.Recent advances in drug delivery systems for targeting cancer stem cells[J].Acta Pharmaceutica Sinica B,2021,第1期 Xiaofei Chen¹，Yunlong Wu²，Chun Chen³，Yanqiu Gu³，Chunyan Zhu²，Suping Wang²，Jiayun Chen²，Lei Zhang¹，Lei Lv⁴，Guoqing Zhang⁴，Yongfang Yuan³，Yifeng Chai¹，Mingshe Zhu⁵，Caisheng Wu²（School of Pharmacy，Naval Medical University；Fujian Provincial Key Laboratory of Innovative Drug Target Research and State Key Laboratory of Cellular Stress Biology，School of Pharmaceutical Sciences，Xiamen University；Department of Pharmacy，Shanghai Ninth People’s Hospital，Shanghai Jiao Tong University；Department of Pharmacy，Shanghai Eastern Hepatobiliary Surgery Hospital，Naval Medical University；Mass Defect Technologies）.Identifying potential anti-COVID-19 pharmacological components of traditional Chinese medicine Lianhuaqingwen capsule based on human exposure and ACE2 biochromatography screening[J].Acta Pharmaceutica Sinica B,2021,第1期 Zhendong Song¹，Meijing Wang²，Yang Ge¹，Xue-Ping Chen¹，Ziyang Xu²，Yang Sun²，Xiao-Feng Xiong¹（Guangdong Key Laboratory of Chiral Molecule and Drug Discovery，School of Pharmaceutical Sciences，Sun Yatsen University；State Key Laboratory of Pharmaceutical Biotechnology，Department of Biotechnology and Pharmaceutical Sciences，School of Life Sciences，Nanjing University）.Tyrosine phosphatase SHP2 inhibitors in tumor-targeted therapies[J].Acta Pharmaceutica Sinica B,2021,第1期 Jiezhou Ye¹，Bo Zeng¹，Meiyan Zhong¹，Hongchun Li²，Lihui Xu³，Junxiang Shu²，Yaofeng Wang¹，Fan Yang¹，Chunsu Zhong¹，Xunjia Ye¹，Xianhui He¹，Dongyun Ouyang¹（Department of Immunobiology，College of Life Science and Technology，Jinan University；Wuzhongpei Memorial Hospital of Shunde；Department of Cell Biology，College of Life Science and Technology，Jinan University）.Scutellarin inhibits caspase-11 activation and pyroptosis in macrophages via regulating PKA signaling[J].Acta Pharmaceutica Sinica B,2021,第1期 Xiaopan Gao¹，Bo Qin¹，Pu Chen¹，Kaixiang Zhu¹，Pengjiao Hou¹，Justyna Aleksandra Wojdyla²，Meitian Wang²，Sheng Cui¹（NHC Key Laboratory of Systems Biology of Pathogens，Institute of Pathogen Biology，Chinese Academy of Medical Sciences and Peking Union Medical College；The Swiss Light Source (SLS) at the Paul Scherrer Institut）.Crystal structure of SARS-CoV-2 papain-like protease[J].Acta Pharmaceutica Sinica B,2021,第1期 Yanying Zhou¹，Xiaomei Fan²，Tingying Jiao¹，Wenzhou Li²，Panpan Chen¹，Yiming Jiang¹，Jiahong Sun¹，Yixin Chen¹，Pan Chen³，Lihuan Guan¹，Yajie Wen¹，Min Huang¹，Huichang Bi¹（School of Pharmaceutical Sciences，Sun Yat-sen University；Shenzhen Baoan Women’s and Children’s Hospital，Jinan University；Department of Pharmacy，the First Affiliated Hospital of Sun Yat-sen University）.SIRT6 as a key event linking P53 and NRF2 counteracts APAP-induced hepatotoxicity through inhibiting oxidative stress and promoting hepatocyte proliferation[J].Acta Pharmaceutica Sinica B,2021,第1期 Bingchen Zhang¹，Jiali Jiang¹，Pengyu Wu¹，Junjie Zou¹，Jingqing Le¹，Juanfang Lin¹，Chao Li¹，Bangyue Luo¹，Yongjie Zhang¹，Rui Huang²，Jingwei Shao^1,2（Fujian Provincial Key Laboratory of Cancer Metastasis Chemoprevention and Chemotherapy，College of Chemistry，Fuzhou University；Institute of Oceanography，Minjiang University）.A smart dual-drug nanosystem based on coassembly of plant and food-derived natural products for synergistic HCC immunotherapy[J].Acta Pharmaceutica Sinica B,2021,第1期 Hao Zengy，Lingling Wangy，Jiawei Zhang，Ting Pan，Yinghua Yu，Jingxia Lu，Ping Zhou，Hua Yang，Ping Li（State Key Laboratory of Natural Medicines，School of Traditional Chinese Pharmacy，China Pharmaceutical University）.Activated PKB/GSK-3β synergizes with PKC-δ signaling in attenuating myocardial ischemia/reperfusion injury via potentiation of NRF2 activity：Therapeutic efficacy of dihydrotanshinone-Ⅰ[J].Acta Pharmaceutica Sinica B,2021,第1期 Kai Yuan^1,2，Xiao Wang^1,2，Haojie Dong^1,2，Wenjian Min^1,2，Haiping Hao^1,2，Peng Yang^1,2（State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Design and Optimization，China Pharmaceutical University；Department of Medicinal Chemistry，School of Pharmacy，China Pharmaceutical University）.Selective inhibition of CDK4/6：A safe and effective strategy for developing anticancer drugs[J].Acta Pharmaceutica Sinica B,2021,第1期 Yilan Shen¹，Wei Chen^2,3，Lei Han²，Qi Bian¹，Jiajun Fan²，Zhonglian Cao²，Xin Jin²，Tao Ding¹，Zongshu Xian²，Zhiyong Guo¹，Wei Zhang⁴，Dianwen Ju²，Xiaobin Mei¹（Department of Nephrology，Changhai Hospital，Second Military Medical University；Department of Biological Medicines，Fudan University School of Pharmacy；Department of Ophthalmology，Stanford University School of Medicine；Department of Nephrology，Shanghai Yangpu Hospital of TCM）.VEGF-B antibody and interleukin-22 fusion protein ameliorates diabetic nephropathy through inhibiting lipid accumulation and inflammatory responses[J].Acta Pharmaceutica Sinica B,2021,第1期 Xiaojie Chen¹，Jiafeng Zou¹，Ke Zhang¹，Jingjing Zhu¹，Yue Zhang¹，Zhihong Zhu¹，Hongyue Zheng²，Fanzhu Li¹，Ji-Gang Piao¹（College of Pharmaceutical Sciences，Zhejiang Chinese Medical University；Libraries of Zhejiang Chinese Medical University，Zhejiang Chinese Medical University）.Photothermal/matrix metalloproteinase-2 dual-responsive gelatin nanoparticles for breast cancer treatment[J].Acta Pharmaceutica Sinica B,2021,第1期 Bing Zhao¹，Xinhui Zhang¹，Tingting Yu¹，Ying Liu¹，Xiaoling Zhang¹，Yongfang Yao¹，Xuejian Feng¹，Hongmin Liu¹，Dequan Yu²，Liying Ma¹，Shangshang Qin¹（State Key Laboratory of Esophageal Cancer Prevention and Treament，Key Laboratory of Technology of Drug Preparation(Zhengzhou University)，Ministry of Education of China，Key Laboratory of Henan Province for Drug Quality and Evaluation，Institute of Pharmaceutical Research and School of Pharmaceutical Sciences，Zhengzhou University；State Key Laboratory of Bioactive Substance and Function of Natural Medicines，Institute of Materia Medica，Chinese Academy of Medical Sciences and Peking Union Medical College）.Discovery of thiosemicarbazone derivatives as effective New Delhi metallo-β-lactamase-1(NDM-1) inhibitors against NDM-1 producing clinical isolates[J].Acta Pharmaceutica Sinica B,2021,第1期 Jinyang Li¹，Jiasheng Lu¹，Haiyan Guo¹，Jianfen Zhou¹，Songli Wang¹，Kuan Jiang¹，Zhilan Chai¹，Shengyu Yao¹，Xiaoyi Wang¹，Linwei Lu²，Cao Xie¹，Yi Chen³，Weiyue Lu^1,4,2,5（Department of Pharmaceutics，School of Pharmacy，Fudan University & Key Laboratory of Smart Drug Delivery(Fudan University)，Ministry of Education and PLA；The Institutes of Integrative Medicine of Fudan University；Chinese Academy of Sciences Shanghai Institute of Materia Medica；State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science，Institutes of Brain Science，Fudan University；Minhang Branch，Zhongshan Hospital and Institute of Fudan-Minghang Academic Health System，Minghang Hospital，Fudan University）.A pentapeptide enabled AL3810 liposome-based glioma-targeted therapy with immune opsonic effect attenuated[J].Acta Pharmaceutica Sinica B,2021,第1期 Xiaosa Changy，Dejuan Suny，Danfeng Shiy，Guan Wang，Yanmei Chen，Kai Zhang，Huidan Tan，Jie Liu，Bo Liu，Liang Ouyang（State Key Laboratory of Biotherapy and Cancer Center，West China Hospital，Collaborative Innovation Center of Biotherapy，Sichuan University）.Design, synthesis, and biological evaluation of quinazolin-4（3H）-one derivatives co-targeting poly （ADP-ribose） polymerase-1 and bromodomain containing protein 4 for breast cancer therapy[J].Acta Pharmaceutica Sinica B,2021,第1期 Shun Zhang^1,2,3，Yan Zhao^2,4,5，Shuyuan Wang^2,3，Min Li^2,3，Yue Xu^2,3，Jianhua Ran⁶，Xiaoqiang Geng²，Jinzhao He^2,3，Jia Meng^2,3，Guangying Shao^2,3，Hong Zhou^2,3，Zemei Ge^2,4，Guangping Chen⁷，Runtao Li^2,4，Baoxue Yang^1,2,3（Department of Pharmacology，School of Basic Medical Sciences，Peking University；State Key Laboratory of Natural and Biomimetic Drugs，Peking University；Key Laboratory of Molecular Cardiovascular Sciences，Ministry of Education；School of Pharmaceutical Sciences，Peking University；College of Pharmacy，Inner Mongolia Medical University；Department of Anatomy and Neuroscience Center，Chongqing Medical University；Department of Physiology，Emory University School of Medicine）.Discovery of novel diarylamides as orally active diuretics targeting urea transporters[J].Acta Pharmaceutica Sinica B,2021,第1期首页上一页 8 9 10 11 下一页尾页共有11页，转到页

期刊文章列表